---------- Forwarded message ----------
Vertex Pharmaceuticals Reports First Quarter 2006 Financial ...
Canada NewsWire (press release) - Canada
.. AACR) in Washington, DC, supporting the clinical investigation of VX-680
in patients with treatment-resistant forms of chronic myelogenous leukemia
(CML). ...
<http://www.newswire.ca/en/releases/archive/April2006/25/c0565.html >
cl;
--~--~---------~--~----~------------~-------~--~----~
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------
You received this message because you are subscribed to the Google Groups "CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at http://groups.google.com/group/CMLHope
-~----------~----~----~----~------~----~------~--~---
